These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3312399)

  • 1. Plasma concentrations of thiothixene and clinical response in treatment-resistant schizophrenics.
    Hollister LE; Lombrozo L; Huang CC
    Int Clin Psychopharmacol; 1987 Jan; 2(1):77-82. PubMed ID: 3312399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-resistant schizophrenia: controlled study of moderate- and high-dose thiothixene.
    Huang CC; Gerhardstein RP; Kim DY; Hollister L
    Int Clin Psychopharmacol; 1987 Jan; 2(1):69-75. PubMed ID: 3312398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penfluridol and thiothixene. Dosage, plasma levels and changes in psychopathology.
    Jacobsson L; von Knorring L; Mattsson B; Mjörndal T; Oreland L; Perris C; Rapp W; Edenius B; Kettner B; Magnusson KE; Villemoes P
    Int Pharmacopsychiatry; 1976; 11(4):206-14. PubMed ID: 795779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
    Sarai K; Okada M
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiothixene plasma levels and clinical response in acute schizophrenia.
    Reifler BV; Ward N; Davis CM; Freidel RO
    J Clin Psychiatry; 1981 May; 42(5):207-11. PubMed ID: 7217026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-refractory chronic schizophrenics: doses and plasma concentrations of thiothixene.
    Kim DY; Hollister LE
    J Clin Psychopharmacol; 1984 Feb; 4(1):32-5. PubMed ID: 6693581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High and low dose thiothixene treatment in chronic schizophrenia.
    Gardos G; Orzack MH; Finn G; Cole JO
    Dis Nerv Syst; 1974 Feb; 35(2):53-8. PubMed ID: 17894041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia.
    Bartlett EJ; Wolkin A; Brodie JD; Laska EM; Wolf AP; Sanfilipo M
    Psychiatry Res; 1991 Oct; 40(2):115-24. PubMed ID: 1763142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum level monitoring of thiothixene in schizophrenia: acute single-dose levels at fixed doses.
    Yesavage JA; Becker J; Werner PD; Mills MJ; Holman CA; Cohn R
    Am J Psychiatry; 1982 Feb; 139(2):174-8. PubMed ID: 7055286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of initial thiothixene serum levels and clinical response. Comparison of fluorometric, gas chromatographic, and RBC assays.
    Yesavage JA; Holman CA; Cohn R; Lombrozo L
    Arch Gen Psychiatry; 1983 Mar; 40(3):301-4. PubMed ID: 6830409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of thiothixene by radioreceptor assay: clinical usefulness.
    Van Putten T; May PR; Marder SR; Wilkins JN; Rosenberg BJ
    Psychopharmacology (Berl); 1983; 79(1):40-4. PubMed ID: 6403963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind trial of thiothixene and chlorpromazine in acute schizophrenia.
    Rickels K; Byrdy H; Valentine J; Postel W; Norstad N; Downing R
    Int Pharmacopsychiatry; 1978; 13(1):50-7. PubMed ID: 342437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of thiothixene plasma levels.
    Mavroidis ML; Kanter DR; Hirschowitz J; Garver DL
    J Clin Psychopharmacol; 1984 Jun; 4(3):155-7. PubMed ID: 6736276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The assessment of thiothixene in chronic schizophrenia. A double-blind controlled trial.
    Burnett GB; Little SR; Graham N; Forrest AD
    Dis Nerv Syst; 1975 Nov; 36(11):625-9. PubMed ID: 1102277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents.
    Realmuto GM; Erickson WD; Yellin AM; Hopwood JH; Greenberg LM
    Am J Psychiatry; 1984 Mar; 141(3):440-2. PubMed ID: 6367494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia and steady-state serum levels of thiothixene.
    Yesavage JA; Tanke ED; Sheikh JI
    Arch Gen Psychiatry; 1987 Oct; 44(10):913-5. PubMed ID: 2889439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels and clinical effects of thioridazine and thiothixene.
    Bergling R; Mjorndal T; Oreland L; Rapp W; Wold S
    J Clin Pharmacol; 1975; 15(2-3):178-86. PubMed ID: 1091665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol and thiothixene in the long-term treatment of chronic schizophrenic outpatients in an urban community: social and vocational adjustment.
    Engelhardt DM; Rudorfer L; Rosen B
    J Clin Psychiatry; 1978 Dec; 39(12):834-40. PubMed ID: 721787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.